Back

Prognostic role of the COAPT risk score in patients with secondary mitral regurgitation (SMR) undergoing M-TEER: Results of a real world registry

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Transcatheter mitral interventions Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Giovanni Martino

University of Calabria, Rende (Italy)

4 More presentations in this session

Presentation thumbnail
Prognostic impact of mitral balloon valvuloplasty for mitral stenosis patients: when the right heart catheterization is the answer
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of conscious sedation or general anesthesia on mitral valve function after percutaneous edge-to-edge reconstruction: a single cohort study
Doctor A. Rroku (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Assessing the impact of transcatheter edge-to-edge repair on reverse remodeling in secondary mitral regurgitation: a systematic review and meta-analysis
Doctor A. Lichtfusz (Budapest, HU) Doctor J. Papp (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Impact of leaflet coaptation gap on procedural and clinical outcomes after transcatheter edge-to-edge-repair for functional mitral regurgitation
Doctor N. Nishiura (Kurashiki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter mitral interventions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Post-procedural mitral regurgitation as an independent predictor of morbidity and mortality outcomes
thumbnail
Congress Presentation
Impact of etiology, age and left ventricular ejection fraction on 12-month mortality effects of transcatheter edge-to-edge repair vs. surgery: a meta-regression analysis
thumbnail
Congress Presentation
Comparison of risk scores for the prediction of 12-months mortality or rehospitalization after interventional treatment of tricuspid regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources